Research Article

Bidirectional Interaction of Thyroid-Kidney Organs in Disease States

Table 6

Mean and standard deviation values of biochemical tests before and after treatment with thyroid hormone replacement therapy in thyroid and kidney dysfunction.

Biochemical testDisease
Primary hypothyroidism (mean ± SD, median)Subclinical hypothyroidism (mean ± SD)Primary hyperthyroidism (mean ± SD)Subclinical hyperthyroidism (mean ± SD)Euthyroidism (mean ± SD)
Before TxAfter Tx valueBefore TxAfter TxBefore TxAfter Tx valueBefore TxAfter TxBefore TxAfter Tx

TSH (NND)N = 11 244.88 ± 392.62 median: 100; Q1: 40.5; Q3: 211.2; IQR: 170.7N = 11 24.28 ± 29.55 median: 10.8; Q1: 2.44; Q3:33.6; IQR: 31.16Result 1⟶ value: 0.003 (SS), z value: −2.93, value: 0; result 2: SS1.44 ± 0.64
fT4 (ND)N = 10 0.44 ± 0.31N = 10 1.14 ± 0.41 value: 0.985 (NS); value: 0.99 (NS)N = 2 37.29 ± 24.57N = 2 2.54 ± 1.361.16 ± 0.16
fT3 (ND)N = 3 1.29 ± 0.68N = 3 2.43 ± 0.82IDN = 2 12.1 ± 4.3N = 2 1. 60 ± 0.99ID2.12 ± 0.22
Total CPK (ND)N = 5 18504.2 ± 31659.8N = 5 624.4 ± 653.44 value: 1 (NS)
Total cholesterol (ND)N = 3 352.6 ± 20.19N = 3 19 ± 18.47ID
Serum creatinine (ND)N = 11 1.67 ± 0.27N = 11 1.45 ± 0.49 value: 0.957 (NS); value: 0.981(NS)N = 2 3.39 ± 1.791.14 ± 0.24

CPK, creatine phosphokinase; fT3, free triiodothyronine; fT4, free thyroxin; ID, insufficient data;IQR, interquartile range; N, number; ND, normally distributed; NDD, nonnormally distributed; NS, not significant; Q1, first quartile ; Q3, third quartile; SD, standard deviation; SS, statistical significant; TSH, thyroid stimulating hormone; Tx, treatment.